Clinical trials
Observational Carcinoma, Transitional Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 8 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pacific Edge Limited | 3 |
| Fox Chase Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| AstraZeneca | 1 |
| Cofactor Genomics, Inc. | 1 |
| Convergent Genomics, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fate Therapeutics | 1 |
| Gritstone bio, Inc. | 1 |
| Indiana University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 24 |
| Urinary Bladder Neoplasms | 10 |
| Carcinoma, Renal Cell | 5 |
| Carcinoma, Hepatocellular | 4 |
| Head and Neck Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 3 |
| Hematuria | 3 |
| Melanoma | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.